HeyJaredClinical Lead
- Indexed articles, last 90 days
- 4
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Selectscience
- Top 5M sites
- Earliest in this view
- Jul 13, 2026
Latest articles
#CLINICAL24 2026 | The Global Clinical Diagnostics Conversation | SelectScience (opens the original)
Read excerpt
Every day, clinical laboratories worldwide help answer some of healthcare’s most important questions. From identifying infections and monitoring chronic disease to supporting life-changing diagnoses, laboratory professionals are vital to patient care. Yet laboratories face constant change: technologies are advancing rapidly, expectations are rising, workforces are evolving, and the potential for diagnostics to improve outcomes continues to grow. At the same time, AI-generated content has surged,
NHS pathology lessons for lab leaders - SelectScience interview (opens the original)
Read excerpt
Every year, clinicians across the UK order more than 2 billion pathology tests. Pathology supports roughly 95% of patient pathways1, informing everything from a GP confirming a diagnosis to an oncologist adjusting chemotherapy. Yet few patients could say what happens between the blood draw and the diagnosis. That gap sits at the heart of the Pathology Transformation Review 2026, an independent review commissioned by the Institute of Biomedical Science (IBMS) and chaired by Lord Carter of Coles.
aaic 2026: advances in earlier Alzheimer’s diagnosis - SelectScience news (opens the original)
Read excerpt
During the AAIC 2026 conference today, one of the experts I interviewed, Dr. Ashton Harper, Global Medical Director of Neurosciences at Roche Diagnostics, told me that 75% of people with dementia, including Alzheimer’s disease, do not have a definitive diagnosis. I later learned that this statistic is widely cited, but it was still shocking to hear in the moment. Underdiagnosis means many people may miss out on timely evaluation, treatment, planning, and support. This affects patients, of course
Pathology Transformation Review 2026: NHS lessons - SelectScience news (opens the original)
Read excerpt
The Pathology Transformation Review 2026, chaired by Lord Carter of Coles and commissioned by the Institute of Biomedical Science (IBMS), sets out a clear case for completing pathology network transformation across the NHS. It calls for stronger workforce planning, better digital infrastructure, consistent national data, and reinvestment of efficiencies into services that directly support patient care. The IBMS has welcomed the review as an evidence-based assessment of the challenges facing path
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Selectscience, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.